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Abstract
Group A Streptococcus (GAS) has long been recognized as a human pathogen causing an
exceptionally broad range of infections. However, despite intense research, the molecular
mechanisms of GAS disease remain unclear. Recently, many important discoveries have
been made that shed light on GAS pathogenesis and open exciting new avenues for future
research. Advances in genome sequencing, microarray technology and proteomic
analysis in combination with the development of more suitable animal models have
dramatically increased the amount of data regarding the mechanisms of GAS
pathogenesis. The information gained from these studies will translate into the
identification of improved diagnostics and new targets for novel therapeutic drugs and
vaccines.

Epidemiologic versatility of group A Streptococcus
The Gram-positive bacterium Streptococcus pyogenes (group A Streptococcus, GAS)
causes a range of human infections such as the clinically uncomplicated conditions
pharyngitis (“strep throat”) and impetigo, whilst also causing severe invasive diseases
including necrotizing fasciitis (NF, “flesh-eating disease”) and streptococcal toxic shock
syndrome (STSS). In addition, the post-infection immune sequelae glomerulonephritis
and acute rheumatic fever may occur. To cause such a wide spectrum of disease, GAS
must be able to adapt to the diverse physiological conditions encountered in the human
host. For example, the pathogen must overcome the first line of physical and immune
defense in saliva to successfully colonize the oropharynx. Moreover, GAS must
disseminate from the initial site of infection to cause invasive disease, a process which
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requires the bacterium to break out of the local site of infection and survive in the blood.
To accomplish each of these transitions, GAS has evolved sophisticated strategies and
complex regulatory mechanisms that allow it to thwart host defenses and successfully
colonize, thrive and/or persist in the host. Many proven and putative virulence factors
made by GAS contribute to host-pathogen interactions (Fig. 1). In this review, we discuss
recent advances in the understanding of GAS pathogenesis and focus on the role of a
variety of streptococcal virulence factors in the establishment and dissemination of
disease. While the mechanistic basis of the regulation of many of these virulence factors
is extremely important, a complete treatment of this topic is beyond the scope of this
review.

Survival of GAS in human saliva
The oropharynx is the primary site of GAS entry into the human host. In this
environment, GAS encounters saliva, which contains components of the innate and the
acquired immune system including antimicrobial peptides that limit the growth of
pathogenic bacteria. It has been known since the 1940s that saliva containing high levels
of GAS plays a role in the person-to-person spread of this pathogen1-3. Recent in vitro
analysis of the interaction between human saliva and GAS reveals that the microorganism
has evolved a mechanism that allows it to persist in saliva at relatively high viable cell
numbers for prolonged periods of time4. This phenomenon is specific for saliva, as GAS
grown in either limited or defined liquid media did not remain viable for long time
periods. It was also demonstrated that serotype M1 strains of GAS reach higher
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concentrations in human saliva than strains of other serotypes. Considering that M1
strains are a leading cause of streptococcal pharyngitis5, it may be that the relatively high
density achieved in saliva by certain GAS serotypes enhances their likelihood of being
transmitted to a new host.
Shelburne et al.6 discovered that a two-component regulatory system of
previously unknown function mediates the persistence of GAS in human saliva. This
two-component system, designated sptR/S for saliva persistence, directly or indirectly
controls expression of about 8% of the GAS genome in exponential growth phase and a
striking 20% of the genome during stationary growth phase6. Of the genes controlled by
sptR/S, genes involved in carbohydrate metabolism are most abundantly represented. One
of the genes discovered to aid GAS survival in saliva is malE, which encodes a highly
conserved maltodextrin-binding protein present in a broad range of GAS strains6,7.
Several lines of evidence suggest that MalE is required for successful interaction of GAS
with human saliva. Firstly, Shelburne et al.7 showed that an isogenic malE mutant is
impaired in its ability to grow and persist in saliva in vitro compared to the parental GAS
strain. These data imply that MalE may play a crucial role in the GAS-saliva interaction
by contributing to nutrient acquisition. Since saliva contains only low levels of glucose,
GAS depends on additional carbon sources for growth. One of the components found in
saliva is amylase, which degrades ingested starch to smaller chains of carbohydrates.
MalE may enable GAS to utilize these particular carbohydrates as additional energy
sources. In addition, MalE may be essential for the earliest stages of GAS colonization as
evidenced by high malE transcript levels early in the GAS-saliva interaction7. Thus,
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human saliva may represent an important reservoir for GAS, which is critical for both
persistence and transmission of the pathogen.

Pharyngeal disease
Although GAS is able to cause serious invasive disease, pharyngitis is by far the most
common infection. For example, ~15 million cases of streptococcal pharyngitis occur
annually in the US alone, resulting in an estimated 2 billion dollars of direct health care
costs8. However, despite decades of research, our knowledge of the precise molecular
events mediating GAS pharyngitis remains rudimentary. Recently, three strategies have
been used to expand our understanding regarding the pathogenesis of this infection. One
line of productive research that has yielded new information about GAS-host interactions
has used mouse nasal-associated lymphoid tissue (NALT)9-11. Use of NALT and a
bioluminescent-tagged GAS strain has suggested that M cells in NALT transport GAS
across the epithelial cell layer, perhaps facilitating invasion of deeper tissues9. NALT
also has been used to study immune responses to GAS10.
A second line of investigation has used gene transcript analysis of GAS in
primary throat swabs obtained from patients with pharyngitis. Virtaneva et al.12 used real
time reverse-transcription PCR (RT-PCR) to study transcripts of 17 GAS genes in throat
swab specimens obtained from 18 pediatric patients diagnosed with acute pharyngitis.
This method allowed the analysis of GAS gene expression in vivo, thereby opening a new
avenue of investigation. Genes belonging to two component regulatory systems,
regulatory genes, and genes encoding proven and putative virulence factors were studied.
Although the level of gene transcripts varied between individuals, several notable trends
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emerged. For example, fasC, a gene encoding a member of a gene regulatory system, was
highly expressed during acute pharyngitis. The fasBCA(X) regulates expression of
fibronectin-binding proteins, superoxide dismutase, streptolysin S-associated genes, and
streptokinase13. Another report suggested that the Fas regulon is upregulated under amino
acid starvation, which may be encountered during initial contact of the pathogen with the
skin and throat or at a site of high cell densities in a nidus of infection14. Virtaneva et al.12
also showed that the mga (multi-gene activator) and perR regulatory genes were highly
expressed during acute pharyngitis. Mga controls expression of genes encoding important
GAS virulence factors including emm (M protein), mac (inhibitor of phagocytosis), and
sic (streptococcal inhibitor of complement), all of which have been implicated in either
adhesion to host cells or evasion from host defenses. Less is known about perR, although
there is evidence that it plays a role in iron homeostasis and the oxidative stress response.
It has been shown to be upregulated in vitro under iron-limiting conditions15, which GAS
may encounter within the host during infection where most iron is sequestered by ironbinding proteins and only minute amounts of free iron are available16. Of the 7
extracellular proteins examined, 4 (scpA [C5a peptidase], bspA [cell surface protein], edin
[homolog to Staphylococcus aureus EDIN toxin],and sda [DNase]) were upregulated
during acute pharyngitis as determined by real-time RT-PCR12.
A third line of research has used a cynomolgus macaque model of pharyngitis
17-19

12,

. Due to high human host specificity of GAS, rodent models are inadequate in their

representation of pharyngitis pathogenesis because they neither precisely mimic human
GAS disease nor the host response against GAS infection.

Virtaneva et al.17 used

expression microarray analysis to study longitudinal changes of GAS gene expression in
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20 cynomolgus macaques experimentally infected with serotype M1 strain MGAS5005.
This strain is genetically representative of M1 GAS strains which are currently
responsible for a large percentage of pharyngitis and invasive infections20. The monkeys
developed acute pharyngitis that was indistinguishable from human infection. This
observation was noteworthy as other non-human primate models such as baboons21 and
rhesus macaques22,23 can be successfully colonized with GAS in the upper respiratory
tract but do not develop pharyngitis that mimics human disease. The discovery that
cynomolgus macaques develop acute streptococcal pharyngitis that is a phenocopy of
human disease has resulted in this animal model being treated as the gold standard for
GAS pharyngitis studies.
Many pathogenic bacteria, including GAS, produce extracellular DNase, and it
has been speculated that GAS DNase functions as a virulence factor. The contribution of
a phage-encoded DNase to the pathogenesis of infection caused by contemporary M1
strains has an interesting history that warrants brief review. In 1989, Stevens and
colleagues24 observed that contemporary episodes of severe invasive GAS infections in
the Rocky Mountain Region of the United States were associated with scarlet fever toxin
A (SpeA), long known to be encoded by a bacteriophage. This crucial observation was
confirmed by analyzing clonal diversity and genetic relationships among 108 strains of
GAS recovered from patients throughout the USA25. Importantly, Southern blot analysis
indicated that there were at least two distinct genotypes of serotype M1 strains, those that
were speA-positive, and those that lacked this gene and presumably the bacteriophage
encoding it. Further analysis revealed that contemporary serotype M1 isolates contained a
distinct speA allele26. Cleary et al.27 confirmed the association of the speA gene with
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severe serotype M1 GAS infections and extended the concept that two distinct subclones
of serotype M1 existed. Importantly, the analysis revealed that relative to speA-negative
strains, speA-positive strains contained approximately 70 kb of additional DNA.
Subsequently, mouse virulence studies showed that speA-positive organisms were
significantly more virulent28. A detailed genetic dissection of 126 GAS strains
demonstrated considerable genetic diversity existed among M1 strains20. The analysis
showed that a distinct virulent serotype M1 subclone had emerged recently and spread
intercontinentally. It was then discovered that some contemporary M1 isolates contain a
gene encoding a DNase that is absent in the genome of strain SF37029. The DNase gene
was linked to a phage gene, providing supportive evidence that contemporary serotype
M1 strains were genetically distinct. Sumby et al.18 sequenced the genome of serotype
M1 strain MGAS5005 and found that it had genes encoding three distinct DNases (spd3,
sdaD2 and spd), two of which are bacteriophage-encoded. Seven isogenic mutant strains
were constructed and used to study the role of DNases in host-pathogen interactions in
vivo18. Importantly, it was found that DNase production is required for normal
progression of both pharyngitis and invasive infections. As part of the innate immune
response to bacterial infection, neutrophils kill bacteria by entanglement in neutrophil
extracellular traps, which consist of DNA and chromatin, and subsequent destruction of
the captured pathogen30. Sumby et al.18 demonstrated that GAS DNase activity is crucial
in assisting GAS to avoid destruction by neutrophils, which was confirmed by other
investigators31.
Two additional recent publications have closed the loop on certain aspects of
genetic differentiation of contemporary and old serotype M1 strains32,33. The occurrence
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of prophages encoding DNases in contemporary M1 isolates was confirmed32. In
addition, Sumby et al.33 sequenced the genome of a contemporary M1 strain and
discovered that this speA-positive genotype originally described in 1991 had a 36-kb
recombination region involving genes encoding several GAS toxins, including
streptolysin O (SLO) and NAD+-glycohydrolase (NADase). Importantly, this
recombination event is associated with significantly increased production of these two
toxins. Sumby et al.33 used the genome sequence information, DNA-DNA microarray,
high-throughput single nucleotide polymorphism analysis, and expression microarray
analysis to reconstruct the molecular evolutionary events that resulted in the genesis of
the abundant serotype M1 clone now responsible for much human disease worldwide.

Vascular leakage and survival of GAS in plasma and blood
When GAS causes superficial infections, it is exposed to human plasma at sites of
inflammation as a consequence of vascular leakage, which is mediated in part by the
interaction of M protein and fibrinogen with the β2-integrin adhesion molecule on the
surface of neutrophils (PMNs). This complex results in a massive inflammatory response
which involves the release of heparin binding protein (HBP) and induces vascular
leakage34.

As

augmented

vascular

permeability

is

one

of

the

underlying

pathophysiological mechanism in shock, the crosslinking of the M protein and fibrinogen
with β2-integrin may play an important role in the establishment of STSS. Plasma is a
rich medium that supports bacterial growth, however it also contains many immune
system components which GAS must elude to survive, including opsonizing antibodies
and complement. Many plasma protein-GAS protein interactions interfere with the proper
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function of host defenses5,35. Moreover, GAS expresses surface proteins that have a high
affinity for several human plasma proteins such as albumin, fibrinogen, α2macroglobulin, IgG, and plasminogen5,35-38, which suggests that the pathogen has evolved
mechanisms to capture and use host proteins for enhanced survival in vivo.
To examine the effect of plasma on GAS protein expression, Johansson et al.39
compared the proteomes of serotype M1 strain AP1 cultured in laboratory medium or in
human plasma. Expression of 39 protein spots representing 24 unique GAS proteins, was
significantly increased in cells cultured in human plasma. Interestingly, multiple spots for
secreted extracellular proteins C5a peptidase and M1 were present in the proteome of
plasma-grown bacteria, but were absent in the proteome of strain AP1 grown in
laboratory medium. Concurrent with these data, a truncated variant of M1 protein lacking
the N-terminal 13 amino acids of the mature, full-length protein was identified, a finding
indicative of post-translational modification of this key virulence factor in response to
plasma exposure39.
We have only limited knowledge of changes in protein expression in GAS
cultured in blood compared to laboratory media. However, Graham et al.40 have
demonstrated that GAS undergoes a rapid and extensive remodeling of its transcriptome
when grown in human blood ex vivo. Within 30 min after initial contact of GAS with
whole blood, transcripts of 716 genes (representing 37% of the GAS genome) were upregulated whereas 425 transcripts (22% of the genome) were down-regulated. Transcripts
of genes belonging to functional categories expected to be important for growth
adaptation in blood including de novo synthesis of macromolecular precursors,
carbohydrate metabolism, membrane transport, and transcriptional regulation were
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increased. Expression of several virulence genes was up-regulated, including the
multigene activator mga and its regulated transcripts emm1, sic, streptolysin, and has
(capsular polysaccharide)40. Evidence for the up-regulation of capsule expression of GAS
in blood in vivo was provided by Gryllos et al.41 who showed that there is a temporal
relationship between capsule gene expression and proliferation of GAS in the blood of
infected mice.

Transition from local to systemic infection
Each year GAS causes an estimated 700 million cases of mild non-invasive
infections such as pharyngitis and impetigo worldwide. Approximately 700,000 of these
develop into severe invasive disease42. The exact mechanism mediating the switch from a
localized to a systemic infection remains to be elucidated. One factor that is thought to
contribute to this process is the binding of GAS to human plasminogen and its subsequent
activation to the broad-spectrum protease plasmin43-47. It was hypothesized that
plasminogen is supplied by vascular leakage at the site of infection. There is evidence
that GAS assembles a trimolecular complex consisting of fibrinogen, plasminogen, and
streptokinase, which is associated with a propensity for invasive disease48,49. Recent
studies using a humanized transgenic mouse model confirmed the important role for
human plasminogen in the dissemination of GAS in vivo37,45 and lead to the proposal that
GAS may subvert human plasminogen for use as a virulence factor36,45. Interestingly,
GAS also produces the cysteine protease SpeB, which has been shown to directly degrade
the trimolecular complex48. Differential regulation of speB expression seems to play a
role in the transitioning from localized to invasive disease. The speB gene is found in
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over 99% of GAS isolates and is highly conserved, and production of SpeB has been
shown to be important in the establishment of localized GAS infections37,50,51. Kansal et
al.52 observed that SpeB levels vary greatly in both clonally related and unrelated strains
and that expression of SpeB and human invasive disease severity are inversely related in
M1T1 GAS isolates. In addition, passage of speB expressing GAS strains in mice
resulted in a downregulation of speB concomitantly with the upregulation of M protein
expression52. Moreover, Cole et al.37 discovered that there is a subpopulation of GAS in
localized infections that can lose SpeB activity. This ultimately results in an
accumulation of plasmin activity on the GAS cell surface and equips this particular
subpopulation with enhanced invasive potential. Ultimately, this may result in the
transition of GAS from the local site of infection to the blood and promotes dissemination
to other parts of the host.
To gain additional information about the GAS genes expressed during skin and
soft tissue infection, Graham et al.53 analyzed the transcriptome of GAS in mouse soft
tissue infection. The transcriptome of a serotype M1 strain was studied, and array
datasets

were

verified

by

quantitative

real-time

RT-PCR

and

in

situ

immunohistochemistry. The results demonstrated that coordinated expression of GAS
virulence factors is directed toward overcoming innate host defenses, resulting in severe
cellular damage. In addition, several classes of genes were found to be highly expressed
in vivo, including oxidative stress genes, virulence genes, genes related to complex
carbohydrate utilization, and several two-component transcriptional regulators.

This

study was the first global analysis of the GAS transcriptome in invasive infection and
produced many new avenues for basic and translational research.
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Severe invasive disease
Severe invasive GAS infections have re-emerged on a global level since the mid1980s. These infections can progress rapidly and are associated with exceedingly high
rates of morbidity and mortality54. Many strains causing necrotizing fasciitis, an
especially severe and destructive infection, are serotype M1 and M3 strains54-56, which
suggests that particular GAS strains have an increased propensity to cause invasive
disease.
Sumby et al.57 described two distinct transcriptome profiles of GAS that were
linked to the type of disease, i.e. pharyngitis or invasive infection. The pharyngeal
transcriptome profile (PTP) and the invasive transcriptome profile (ITP) differ
significantly in expression of approximately 10% of the genome, including genes of
several proven and putative virulence factors. Strains of the PTP were able to transition to
the ITP phenotype during invasive infections, but strains of the ITP phenotype did not
convert to the PTP phenotype under the conditions tested. Strains of the ITP phenotype
were more resistant than PTP organisms to phagocytosis and killing by human
neutrophils. To discover the genetic changes underlying the two distinct transcriptome
profiles, complete genome re-sequencing of a mouse-derived ITP strain was conducted57.
The genome of the ITP derivative organism differed from the PTP precursor strain by
only a 7-bp frameshift mutation located in the covS gene, which encodes the sensor
kinase of the CovR/S two-component regulatory system. CovR/S directly or indirectly
controls approximately 15% of the GAS transcriptome58.

The frameshift mutation

truncates CovS, resulting in the de-repression of many genes encoding proven virulence
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factors, including speA (streptococcal pyrogenic exotoxin A), sagA (streptolysin S), mac,
ska (streptokinase), and spd3. Consistent with these findings, Engleberg et al.59 reported
that spontaneous mutations in CovR/S result in increased virulence in murine skin and
soft tissue infections. Thus, the transcriptome profile and the virulence character of GAS
are intimately linked to the allelic state of the genes encoding the CovR/S two-component
system.
Several lines of evidence have recently implicated a GAS extracellular protease
(termed ScpC or SpyCEP) that cleaves interleukin-8 (IL-8) in invasive disease60-62. IL-8
is a chemoattractant that promotes recruitment of neutrophils to the site of infection by
promoting their migration out of the bloodstream. Thus, the ability of GAS to impair the
activity of IL-8 during infection may enhance its survival during infection and aid in its
dissemination within the host. SpyCEP specifically cleaves the carboxy-terminus of IL-8,
resulting in inactivation of the chemoattractant property of this molecule. This enzyme
also cleaves and inactivates mouse chemokines known as KC and MIP-262. HidalgoGrass et al.62 reported that inactivation of the gene encoding SpyCEP impairs GAS
clearance from infected mouse tissue and is associated with decreased soft tissue
infection.
There is also evidence that mtsR, a gene encoding a metal transport regulator, may
play a role in deep-muscle infections63-65. Using comparative genome re-sequencing,
Beres et al.65 discovered that strains containing a naturally occurring mutation in mtsR,
which yields a severely truncated MtsR protein, are significantly underrepresented among
GAS isolates recovered from necrotizing fasciitis cases. These results suggest that MtsR
is necessary for the full virulence potential of GAS in invasive disease. Expression
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microarray analysis found that this truncation mutation is linked to significantly altered
transcript levels of multiple genes and operons involved in metal homeostasis and
response to oxidative stress65, which perhaps renders the pathogen more vulnerable to the
host immune response.
The molecular processes contributing to tissue destruction in GAS necrotizing
fasciitis and myonecrosis remain poorly understood.

Recent studies have provided

important evidence that streptolysin O-induced platelet/neutrophil complexes play a role
in development of ischemic necrosis of tissue66. In related work, Bryant et al.67 showed
that an early step in the pathogenesis of GAS myonecrosis may involve binding of the
pathogen to vimentin, a molecule that is up-regulated after skeletal-muscle injury.

Asymptomatic carriage
GAS is exclusively a human pathogen and therefore must survive in a human reservoir.
Many individuals carry GAS asymptomatically in the upper respiratory tract and other
anatomic sites. Over the years there have been several hypotheses to explain this
phenomenon. In principle, asymptomatic carriage of GAS could arise as a consequence
of mutations in the pathogen that down-regulate virulence, a productive immune response
by the host that constrains pathogen proliferation, internalization into host cells, or some
combination thereof.

Relatively little work has been done to study the genetic

relationships between strains causing disease episodes and those of the same M protein
serotype that are recovered from asymptomatic carriers. However, this issue can now be
studied at the genome-wide level. To address this issue, Beres et al.68 used comparative
genome re-sequencing to show that several serotype M3 strains from asymptomatic
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throat carriers contained deletion mutations in the pleiotrophic virulence regulatory gene
mga and the emm gene. The occurrence of these mutations in the carrier isolates but not
in disease-causing organisms implicates them in down-regulating virulence. Consistent
with this idea, carrier strains were significantly less virulent, as assessed by
intraperitoneal injection into mice68.

Thus, these data support the hypothesis that

asymptomatic carriage may arise as a consequence of mutations that down-regulate
virulence.
While GAS has long been regarded as an extracellular pathogen, there has been
evidence that it can invade non-phagocytic cells69-72. This observation has led to
conjecture that internalization of GAS by host cells participates in the carrier state5,70,73.
GAS internalization may allow the pathogen to evade certain host defenses and protect it
from killing by antibiotics such as penicillin, as this antibiotic does not enter epithelial
cells70. Consistent with this idea, Sela et al.70 observed that strains escaping antibiotic
killing had significantly higher internalization efficiencies than strains that were
successfully eliminated by antibiotic therapy. Other investigators have reported that
genes encoding proteins that are linked to internalization, such as those encoding
fibronectin-binding proteins F2, SfbI, and PfbpI, are significantly more prevalent among
persisting GAS strains recovered from asymptomatic carriers5,73. However, Brandt et
al.74 found no evidence for an increased prevalence of the prtF1 gene among GAS
isolates recovered from pharyngitis patients who had antibiotic treatment failure. Hence,
the literature bearing on this issue remains unclear and additional work is required to
elucidate the role of host-cell internalization in asymptomatic carriage and other aspects
GAS biology and pathogenesis.
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Asymptomatic carriage of GAS also may have a role in some invasive infections.
Medina and colleagues observed that the intracellular survival of GAS in neutrophils may
result in increased bacterial virulence75. Using a mouse model, it was shown that ingested
GAS is transported by neutrophils to distant parts of the body75. This is a notable finding
as it may explain the cases of necrotizing fasciitis occurring in the absence of an entry
wound or trauma adjacent to the site of GAS infection.

Concluding remarks
This review has highlighted some recent advances in our understanding of GAS
pathogenesis and its interaction with the human host at various sites of infection. Many of
the important findings have been made possible by contemporary genome sequencing,
microarray technology and proteome analysis. Combined use of these technologies
permits a global interrogation of molecular events that occur during host-pathogen
interactions. Their use has revealed that GAS responds rapidly and in a regulated manner
to the distinct environments encountered in the host during the establishment and
dissemination of disease (Fig. 2). In the future, these approaches will be useful in
identifying molecular markers specific for each phase of the disease process. This is
especially important for severe invasive GAS diseases, which progress rapidly and are
frequently diagnosed too late due to the current lack of appropriate diagnostics.
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Box 1: Outstanding questions:
What are the molecular markers in the initial stages of severe invasive diseases such as
streptococcal toxic shock syndrome and necrotizing fasciitis?

What is the molecular mechanism responsible for severe invasive GAS infections?

What host factors are involved in the development of, as well as the susceptibility to,
severe invasive disease?

What is/are the environmental signal(s) that cause the transcriptional switch from noninvasive to severe invasive streptococcal disease?
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Figure Legends
Figure 1: GAS virulence factors interact with the host at multiple levels. GAS has an
arsenal of virulence factors at its disposal that allow it to successfully colonize and thrive
in the host. At the cell and tissue level, these factors contribute to the pathogenicity of
GAS by mediating adherence to host cells, by promoting internalization and invasion,
and by evading phagocytosis. At the organism level, the virulence factors are involved in
facilitating dissemination throughout the host and can induce systemic toxicity.
Importantly, many of the proven streptococcal virulence factors function at multiple
stages of infection.

Figure 2: Group A Streptococcus modifies the transcription of genes belonging to
diverse functional groups during infection. GAS causes many different human
infections, reflecting its ability to adapt to diverse physiological conditions. Several
recent studies have investigated GAS transcriptome remodeling in pharyngitis17] and
invasive soft-tissue infection53, and during growth in saliva6 and blood40.
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Figure 2: Group A Streptococcus Modifies transcription of genes belonging to diverse functional
categories during infection.

